Anti-Obesity and Gut Microbiota Regulation Effects of Phospholipids from the Eggs of Crab, Portunus Trituberculatus, in High Fat Diet-Fed Mice

Mar Drugs. 2022 Jun 23;20(7):411. doi: 10.3390/md20070411.

Abstract

There are resourceful phospholipids in the eggs of the crab, Portunus trituberculatus (Pt-PL). However, their components and bioactivities regarding obesity were unclear. Here, we investigated the composition of Pt-PL and their fatty acids. Moreover, its effects on obesity and gut microbiota were also evaluated in high fat diet (HFD)-fed mice. The results showed that Pt-PL contained 12 kinds of phospholipids, mainly including phosphatidylcholine (PC, 32.28%), phosphatidylserine (PS, 26.51%), phosphatidic acid (PA, 19.61%), phosphatidylethanolamine (PE, 8.81%), and phosphatidylinositol (PI, 7.96%). Polyunsaturated fatty acids (PUFAs) predominated in the fatty acids components of Pt-PL, especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Animal experiments demonstrated that Pt-PL significantly alleviated body weight gain, adipose gain, hepatic gain, fasting blood glucose, serum insulin, lipid levels in serum and the liver, and systematic inflammation in HFD-fed mice. Furthermore, Pt-PL regulated gut microbiota, especially in a dramatic reduction in the ratio of Firmicutes to Bacteroidetes at phylum level, as well as significant amelioration in their subordinate categories. Pt-PL reduced fecal lipopolysaccharide and total bile acids, and elevated fecal short chain fatty acid (SCFA) concentrations, particularly acetate and butyrate. These findings suggest that Pt-PL possesses anti-obesity effects and can alter gut microbiota owing to the abundance of PUFAs. Therefore, Pt-PL may be developed as an effective food supplement for anti-obesity and regulation of human gut health.

Keywords: Portunus trituberculatus eggs; anti-obesity; composition of fatty acids; gut microbiota; phospholipids.

MeSH terms

  • Animals
  • Brachyura*
  • Diet, High-Fat / adverse effects
  • Fatty Acids / pharmacology
  • Gastrointestinal Microbiome*
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Obesity / drug therapy
  • Obesity / etiology
  • Phospholipids / pharmacology

Substances

  • Fatty Acids
  • Phospholipids

Grants and funding

This research was supported by Science and Technology Project of Zhoushan (2020C21020), Zhejiang Provincial Universities and Research Institutes (2021JZ004), Public Projects of Zhejiang Province (LGN19D060001), Key Scientic and Technological Innovation Project of Wenzhou (ZS2019001 and ZD202003), Public Welfare Projects in Zhejiang Province (LGN20C200003), Wenzhou Science and Technology Commissioner Project (X20210015), and Zhejiang Fishery Industry Technology Project (2020–2022).